phentermine

(redirected from Qsymia)
Also found in: Dictionary.
Related to Qsymia: phentermine, Topiramate, Belviq

phentermine

 [fen´ter-mēn]
a sympathomimetic amine related to amphetamine, used as an appetite suppressant either as the hydrochloride salt or as the base in a complex with a resin, which has a sustained action.

phentermine

/phen·ter·mine/ (fen´ter-mēn) a sympathomimetic amine related to amphetamine, used as an anorectic either as the hydrochloride salt or as the base complexed with an ion exchange resin.

phentermine

(fĕn′tər-mēn′)
n.
A drug, C10H15N, that suppresses appetite by altering the metabolism of the neurotransmitter norepinephrine and is used in its hydrochloride form in the management of obesity.

phentermine

A drug with an AMPHETAMINE (amfetamine)-like action used for appetite control in obesity. A brand name is Duromine. There is evidence that phentermine may be associated with heart valve disease and pulmonary hypertension.

Phentermine

An amphetamine prescribed for appetite suppression.
Mentioned in: Weight Loss Drugs
References in periodicals archive ?
In phase III clinical trials of Qsymia, quite a few women got pregnant, which is not surprising, since women who are obese may have more difficulty knowing they are pregnant, for hormonal and other reasons.
The FDA said that two studies conducted on patients who took Qsymia, along with changing their diet and increasing exercise, showed an average weight loss of 6.
As a combination therapy with two active ingredients that needed to be formulated and delivered in a controlled release dosage form, Qsymia presented unique formulation and drug delivery challenges.
The late-stage clinical trial results for its weight-loss drug Qsymia were promising, so I bought back around $20 when the FDA approved Qsymia.
drug, known as Qsymia (phentermine and topiramate), was approved in July
ScinoPharm), a leading active pharmaceutical ingredients (API) maker in Taiwan, recently announced that its pharmaceutical factory in Tainan, southern Taiwan, will supply the topiramate active API for VIVUS's Qsymia, a new drug to treat obesity that is approved by the U.
Among the new agents to enter the market, Vivus's Qsymia will become the most widely used emerging therapy due to efficacy superior to its competitors.
Status Report: Contrave, Qsymia & Belviq sales & outlooks, FDA rejections of: Acomplia, Taranabant, other Rx diet drugs
In September, VIVUS launched Qsymia for obesity in the U.
If proven safe, GBI Research expects the sales of Qsymia and other drugs expected to be approved over the forecast period to increase the market size to $2.
He then gave a qualified shout out to the two newly FDA-approved weight loss drugs, Qsymia, which combines phentermine and topiramate, and lorcaserin, Belviq.